Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed in E. coli

Aberrant glycosylation is one of the major hallmarks of cancer with altered gene expression signatures of sialyltransferases. ST3Gal-I, a sialyltransferase, is known to play a crucial role in sialylation of T antigen in bladder cancer and it has reported elevated expression in breast carcinogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Anuj Kumar, Kaur, Parvinder, Patil, Harshada, Kadam, Pallavi, Bhanushali, Paresh B., Chugh, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689901/
https://www.ncbi.nlm.nih.gov/pubmed/26783462
http://dx.doi.org/10.1155/2015/767204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689901/
https://www.ncbi.nlm.nih.gov/pubmed/26783462
http://dx.doi.org/10.1155/2015/767204

Ejemplares similares